These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31054790)

  • 1. Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella.
    Bradley BT; Bryan A
    Semin Diagn Pathol; 2019 May; 36(3):152-159. PubMed ID: 31054790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season.
    Jiang C; Yao X; Zhao Y; Wu J; Huang P; Pan C; Liu S; Pan C
    Microbes Infect; 2020; 22(6-7):236-244. PubMed ID: 32405236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical presentation and outcomes of children infected with newly identified respiratory tract viruses.
    Williams JV
    Infect Dis Clin North Am; 2005 Sep; 19(3):569-84. PubMed ID: 16102649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].
    Liu M; Feng RE; Li Q; Zhang HK; Wang YG
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):511-516. PubMed ID: 32392945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coronaviruses as the cause of respiratory infections].
    Corman VM; Lienau J; Witzenrath M
    Internist (Berl); 2019 Nov; 60(11):1136-1145. PubMed ID: 31455974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.
    Wu Z; Harrich D; Li Z; Hu D; Li D
    Rev Med Virol; 2021 Mar; 31(2):e2171. PubMed ID: 33350025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for emerging respiratory viruses.
    Al-Tawfiq JA; Zumla A; Gautret P; Gray GC; Hui DS; Al-Rabeeah AA; Memish ZA
    Lancet Infect Dis; 2014 Oct; 14(10):992-1000. PubMed ID: 25189347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MERS, SARS and other coronaviruses as causes of pneumonia.
    Yin Y; Wunderink RG
    Respirology; 2018 Feb; 23(2):130-137. PubMed ID: 29052924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), influenza, and COVID-19, beyond the lungs: a review article.
    Lombardi AF; Afsahi AM; Gupta A; Gholamrezanezhad A
    Radiol Med; 2021 Apr; 126(4):561-569. PubMed ID: 33242204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
    Kumar V
    Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emerging infectious agents].
    Chidiac C; Ferry T
    Transfus Clin Biol; 2016 Nov; 23(4):253-262. PubMed ID: 27644171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Practice and thinking of acute respiratory infection surveillance for the response of emerging respiratory diseases in Shanghai].
    Chen J; Zheng YX; Kong DC; Wu HY; Yuan ZA; Wu F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):1994-1998. PubMed ID: 32539259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The First Pediatric Patients with Coronavirus Disease 2019 (COVID-19) in Japan: Risk of Co-Infection with Other Respiratory Viruses.
    Kakuya F; Okubo H; Fujiyasu H; Wakabayashi I; Syouji M; Kinebuchi T
    Jpn J Infect Dis; 2020 Sep; 73(5):377-380. PubMed ID: 32475878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
    Panatto D; Orsi A; Pennati BM; Lai PL; Mosca S; Bruzzone B; Caligiuri P; Napoli C; Bertamino E; Orsi GB; Manini I; Loconsole D; Centrone F; Pandolfi E; Ciofi Degli Atti ML; Concato C; Linardos G; Onetti Muda A; Raponi M; Piccioni L; Rizzo C; Chironna M; Icardi G
    PLoS One; 2021; 16(12):e0260947. PubMed ID: 34874956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.